Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation-Reference-Cited by-同舟云学术

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

Published:2010-03-21 Issue:4 Volume:16 Page:470-474
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Rudolph Volker,Andrié René P,Rudolph Tanja K,Friedrichs Kai,Klinke Anna,Hirsch-Hoffmann Birgit,Schwoerer Alexander P,Lau Denise,Fu XiaoMing,Klingel Karin,Sydow Karsten,Didié Michael,Seniuk Anika,von Leitner Eike-Christin,Szoecs Katalin,Schrickel Jan W,Treede Hendrik,Wenzel Ulrich,Lewalter Thorsten,Nickenig Georg,Zimmermann Wolfram-Hubertus,Meinertz Thomas,Böger Rainer H,Reichenspurner Hermann,Freeman Bruce A,Eschenhagen Thomas,Ehmke Heimo,Hazen Stanley L,Willems Stephan,Baldus Stephan

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2124.pdf

Reference37 articles.

1. Issac, T.T., Dokainish, H. & Lakkis, N.M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J. Am. Coll. Cardiol. 50, 2021–2028 (2007).

2. Kannel, W.B., Wolf, P.A., Benjamin, E.J. & Levy, D. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol. 82, 2N–9N (1998).

3. Nattel, S. & Opie, L.H. Controversies in atrial fibrillation. Lancet 367, 262–272 (2006).

4. Kannel, W.B., Abbott, R.D., Savage, D.D. & McNamara, P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N. Engl. J. Med. 306, 1018–1022 (1982).

5. Aviles, R.J. et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108, 3006–3010 (2003).

Cited by 288 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pivotal role of neutrophil extracellular traps in cardiovascular diseases: Mechanisms and therapeutic implications;Biomedicine & Pharmacotherapy;2024-10

2. Myeloperoxidase and N-terminal pro-atrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation;Heart Rhythm O2;2024-09

3. Inhibition of myeloperoxidase to treat left ventricular dysfunction in non‐ischaemic cardiomyopathy;European Journal of Heart Failure;2024-08-30

4. Construction of CDs@β-CD@CCM ratiometric fluorescence probe for FRET-based ClO^–-sensing;Nanotechnology;2024-08-27

5. Comprehensive mendelian randomization reveals atrial fibrillation-breast cancer relationship and explores common druggable targets;Frontiers in Pharmacology;2024-08-07